Skip to main content
Headlines

In the News

In the News highlights media coverage featuring the Johns Hopkins Bloomberg School of Public Health.

The New York Times
|

Tattoo Artists Face a Grayer Palette in Europe

The E.U. has prohibited some pigments, deeming them potentially hazardous to humans. Artists and manufacturers around the world are struggling to find replacements.
 

Slate
|

Traffic Safety Ads Are Better at Making Puns Than Saving Lives

It’s hard to dispute the urgency of protecting American road users; traffic deaths are rising at the fastest rate on record, particularly in urban areas. On a per capita basis, walking, biking, or driving is significantly more dangerous in the United States than in other developed countries.
 

The New York Times
|

New Experimental Therapy for A.L.S. Approved in Canada

An experimental therapy for A.L.S., the paralyzing and fatal neurological disorder also known as Lou Gehrig’s Disease, has been approved in Canada, adding a new treatment option for a disease for which there are few effective therapies. The FDA is currently reviewing the drug, and has raised questions about the treatment’s effectiveness.
 

Reuters
|

U.S. seeks to expand monkeypox testing as cases rise

U.S. health officials are working to expand capabilities to test for monkeypox beyond a narrow group of public health labs, heeding calls from infectious disease experts who say testing for the virus needs to become part of routine care.
 

The Wall Street Journal
|

Can I Trust My Rapid Covid-19 Test if It Says I’m Negative?

With Americans largely returning to prepandemic habits, and precautions such as mask mandates dropped, many people have come to rely on rapid testing to avoid spreading the virus. But with so many people having symptoms and still testing negative, it’s hard to know whether to trust the results.